Android apps for doctors
32 – 31Doximity by 1
| Dimension | Doximity | Lexicomp | Gap |
|---|---|---|---|
| Clinical scope & reasoningHow much of the clinical job the app does, and whether it reasons or only retrieves. Single-purpose references score lower here regardless of how good they are at their one job. | 8 | 4 | +4 |
| Offline & storageHow much content lives on the device, whether it can be stored on external storage, and what remains usable with no connection — a decision factor on shared ward hardware with patchy coverage. | 6 | 10 | -4 |
| Android build qualityWhether the Android app is maintained at parity with the iOS one: current Material design, adaptive layouts for tablets and foldables, back-gesture and notification behaviour, and how recently it shipped a real update rather than a compatibility bump. | 7 | 6 | +1 |
| Enterprise & device managementDeployability on hospital-owned hardware: Android Enterprise work profiles, managed Google Play distribution, MDM and Samsung Knox compatibility, SSO, and a BAA that covers the mobile client. | 8 | 7 | +1 |
| Access & eligibilityWho can actually install and use it, weighted as heavily as what it costs: Google Play price and subscription cost, free tier size, and the gates in front of it — clinician-verification requirements, country availability and language coverage. This carries particular weight on Android, whose install base is overwhelmingly outside the United States. | 3 | 4 | -1 |
Doximity
- Best for
- US physicians on Android who want an evidence-grounded assistant, a visit scribe, secure messaging and a private-number Dialer in one free, HIPAA-compliant app with a BAA. For a clinician who clears verification, nothing else here delivers as much for nothing.
- Limitation
- Eligibility is what caps it at 3 out of 10 on access and drops it down this page: registration requires US clinician verification, which excludes the large majority of the world's Android users — a heavier penalty here than on iOS, because Android's install base is overwhelmingly outside the United States, and a harder constraint than price, since a paid app can at least be bought. The Android build also trails the iOS one on polish, and little of it works without a connection.
- Price
- Free for verified US clinicians only
Lexicomp
- Best for
- Pharmacists and specialists who need drug data that is both deeper than Epocrates and completely available offline: detailed monographs, IV compatibility, pharmacogenomics and current shortage data, all stored on the device.
- Limitation
- Drug reference only, subscription-gated with no meaningful free tier, and an interface built for depth rather than speed. It scores 4 out of 10 on both clinical scope and access.
- Price
- Subscription; commonly held institutionally
